CTMX — CytomX Therapeutics, Inc. | XLV Holdings | StockAdder

(CTMX)

CytomX Therapeutics, Inc.

Live chart and latest CTMX stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

CTMX News

Analysts bullish on CytomX Therapeutics (CTMX) as CTMX prices $250 million offering

Apr 15, 2026 Yahoo Finance

CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress

Apr 14, 2026 Insider Monkey

CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress

Apr 14, 2026 MSN

CytomX Therapeutics (CTMX) making progress on key metastatic colorectal cancer treatment

Apr 15, 2026 simplywall.st

Is CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Jan 23, 2026 Stock Titan

CytomX seeks $250M stock sale to fund Varseta-M, pipeline programs

Mar 16, 2026 Yahoo Finance

CytomX Therapeutics (CTMX) Reports Q4 Loss, Misses Revenue Estimates

Mar 16, 2026 Yahoo Finance

CytomX Therapeutics' (NASDAQ:CTMX) investors will be pleased with their incredible 402% return over the last year

Jan 16, 2026 Yahoo Finance

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

Mar 17, 2026 MSN

CytomX Therapeutics (CTMX) gains analyst confidence on trial progress

Apr 13, 2026 Yahoo Finance

Downgrade: Here's How Analysts See CytomX Therapeutics, Inc. (NASDAQ:CTMX) Performing In The Near Term

Nov 13, 2025 Yahoo Finance

Barclays Raises its Price Target on CytomX Therapeutics, Inc. (CTMX) to $10 and Maintains an Overweight Rating

Feb 17, 2026 Yahoo Finance

Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress

Dec 21, 2025 Stock Titan

Biotech CytomX prices $250M stock sale to fund Varseta-M

Mar 17, 2026 Yahoo Finance

Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX)